Dr. Siler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 First Capitol Dr
Suite 470
Saint Charles, MO 63301Phone+1 636-946-1650Fax+1 636-947-6621
Summary
- Dr. Thomas Siler is a pulmonologist in Saint Charles, MO and is affiliated with SSM Health St. Joseph Hospital - St. Charles. He received his medical degree from University of Kansas School of Medicine and has been in practice 33 years. He is experienced in pulmonary and sleep medicine and is medical director of pulmonary rehab and sleep medicine at SSM Health St. Joseph Hospital - St. Charles. He is also been involved in over 180 clinical trials since 1992.
Education & Training
- SSM Health/Saint Louis University School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 1984 - 1987
- University of Kansas School of MedicineResidency, Internal Medicine, 1981 - 1984
- University of Kansas School of MedicineClass of 1981
Certifications & Licensure
- MO State Medical License 1983 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- St. Louis Best Doctors St. Louis Magazine, 2006, 2008-2012, 2015, 2019-2022
- CMS Meaningful Use Stage 1 Certification Intergy EHR, Greenway Health, LLC, 2013
Clinical Trials
- HVNI Ambulation Feasibility Study Start of enrollment: 2018 Nov 21
- A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD Start of enrollment: 2020 Sep 22
Publications & Presentations
PubMed
- Reply to Gan, to Calzetta, and to Poor.Antonio Anzueto, Igor Z Barjaktarevic, Thomas M Siler, Tara Rheault, Thomas Bengtsson
American Journal of Respiratory and Critical Care Medicine. 2024-01-15 - 19 citationsEnsifentrine, a Novel Phosphodiesterase 3 and 4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease: Randomized, Double-Blind, Placebo-controlled, Mul...Antonio Anzueto, Igor Z Barjaktarevic, Thomas M Siler, Tara Rheault, Thomas Bengtsson
American Journal of Respiratory and Critical Care Medicine. 2023-08-15 - 10 citationsIcenticaftor, a CFTR Potentiator, in COPD: A Multicenter, Parallel-Group, Double-Blind Clinical Trial.Fernando J Martinez, Gerard J Criner, Christian Gessner, Margret Jandl, Fernando Scherbovsky
American Journal of Respiratory and Critical Care Medicine. 2023-08-15
Press Mentions
- HEALTH MATTERS: Dangerous Magnets, Sleep and Stroke Risk, and Pancreatic CancerJanuary 7th, 2020
Professional Memberships
- Fellow
- Member
- Fellow
- European Respiratory SocietyMember
- National Association for Direction of Respiratory CareMember
- Member
External Links
- Midwest Chest Consultants, PChttp://www.midwestchest.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: